Key result
Estrogen replacement therapy in postmenopausal women was associated with significantly lower renin levels (12.0 vs 16.6 mU/L; P=0.001) compared to women without ERT.
Why the study?
Does estrogen replacement therapy alter the components of the renin-angiotensin system in postmenopausal women?
Population
672 individuals from a population-based sample, including postmenopausal women with estrogen replacement…
Comparison
Estrogen replacement therapy (oral or transdermal) vs Postmenopausal women without estrogen…
Design
Cross-sectional
Authors
Loading...
Should not yet influence ERT decisions; leaves open RAS-mediated effects on outcomes.
Observational (n=672)
Does estrogen replacement therapy alter the components of the renin-angiotensin system in postmenopausal women?
Absolute Event Rate: 12% vs 16.6%
p-value: p=.001
Estrogen replacement therapy in postmenopausal women is associated with a substantial suppression of renin alongside the known induction of angiotensinogen.
Schunkert et al. (1997) conducted an observational in Postmenopausal women (n=672). Estrogen replacement therapy (ERT) vs. Women without ERT and age-matched men was evaluated on Renin levels (p=.001). Estrogen replacement therapy in postmenopausal women was associated with significantly lower renin levels (12.0 vs 16.6 mU/L; P=0.001) compared to women without ERT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: